查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1668117

哌嗪市场 - 全球产业规模、份额、趋势、机会和预测，按来源（天然、合成）、最终用途（医药、农业化学品、个人护理和化妆品、其他）、按地区和竞争细分，2020-2030 年预测

Piperazine Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Source (Natural, Synthetic), By End-use (Pharmaceutical, Agrochemicals, Personal Care & Cosmetics, Others), By Region and Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 187 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

2024 年全球哌嗪市场价值为 34.5 亿美元，预计到 2030 年将达到 44.9 亿美元，预测期内复合年增长率为 4.44%。全球哌嗪市场因其在製药、化学品和工业过程中的广泛应用而正在稳步增长。哌嗪是一种含有两个氮原子的六元杂环结构的有机化合物，主要用作合成各种药物、树脂和腐蚀抑制剂的中间体。哌嗪衍生物的需求不断增加，特别是用于治疗寄生虫感染和神经系统疾病的製药行业的需求，正在推动市场扩张。根据 MDPI 发表的一篇文章，哌嗪是药物研发中第三常见的氮杂环化合物，是几种畅销药物的关键成分，包括伊马替尼（以 Gleevec 为商品名销售）和西地那非（以 Viagra 为商品名销售）。儘管哌嗪在药物化学中有着广泛的应用，但其结构多样性仍然有限，大约80%的含哌嗪药物的取代基仅在氮位置上。

市场概况
预测期 2026-2030
2024 年市场规模 34.5 亿美元
2030 年市场规模 44.9 亿美元
2025-2030 年复合年增长率 4.44％
成长最快的领域 合成的
最大的市场 亚太地区

哌嗪市场的主要驱动因素之一是其在製药业中的作用。哌嗪衍生物如柠檬酸盐和己二酸盐通常用作驱虫药，用于治疗寄生虫引起的感染。此外，哌嗪是合成精神病药物和抗发炎药物的关键中间体。寄生虫感染盛行率的上升，加上对有效药物的需求不断增加，推动了哌嗪类药物的消费。推动市场成长的另一个重要因素是其在化学和聚合物工业中的应用。哌嗪用于生产环氧树脂，而环氧树脂是涂料、黏合剂和复合材料中必不可少的原料。此外，它还可作为聚氨酯和聚酰胺树脂的固化剂，增强其机械性能。建筑、汽车和航太工业的不断发展导致对哌嗪基树脂和聚合物的需求不断增加。

主要市场驱动因素

药品需求不断成长

主要市场挑战

供应链中断和区域依赖性

主要市场趋势

碳捕获技术需求不断成长

目录

第 1 章：产品概述

第 2 章：研究方法

第 3 章：执行摘要

第四章：COVID-19 对全球哌嗪市场的影响

第五章：全球哌嗪市场展望

  • 市场规模和预测
    • 按价值和数量
  • 市场占有率和预测
    • 按来源（天然、合成）
    • 依最终用途分类（医药、农业化学品、个人护理及化妆品、其他）
    • 按地区
    • 按公司分类（2024）
  • 市场地图

第六章：北美哌嗪市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 北美：国家分析
    • 墨西哥
    • 加拿大

第七章：欧洲哌嗪市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 欧洲：国家分析
    • 德国
    • 英国
    • 义大利
    • 西班牙

第 8 章：亚太地区哌嗪市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 亚太地区：国家分析
    • 印度
    • 韩国
    • 日本
    • 澳洲

第九章：南美洲哌嗪市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 南美洲：国家分析
    • 阿根廷
    • 哥伦比亚

第 10 章：中东和非洲哌嗪市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • MEA：国家分析
    • 沙乌地阿拉伯
    • 阿联酋

第 11 章：市场动态

  • 驱动程式
  • 挑战

第 12 章：市场趋势与发展

  • 合併与收购（如有）
  • 来源启动（如果有）
  • 最新动态

第 13 章：全球哌嗪市场：SWOT 分析

第 14 章：波特五力分析

  • 产业竞争
  • 新进入者的潜力
  • 供应商的力量
  • 顾客的力量
  • 替代产品的威胁

第 15 章：竞争格局

  • BASF SE
  • Dow Inc.
  • Evonik Industries AG
  • Solvay SA
  • Albemarle Corporation
  • Shell plc
  • Huntsman Corporation
  • Akzo Nobel NV
  • Diamines and Chemicals Limited (DACL)
  • Shaoxing Xingxin New Materials Co., Ltd

第 16 章：策略建议

第17章 调査会社について・免责事项

简介目录
Product Code: 27710

Global Piperazine Market was valued at USD 3.45 Billion in 2024 and is expected to reach USD 4.49 Billion by 2030 with a CAGR of 4.44% during the forecast period. The global piperazine market is witnessing steady growth due to its widespread applications in pharmaceuticals, chemicals, and industrial processes. Piperazine, an organic compound with a six-membered heterocyclic structure containing two nitrogen atoms, is primarily used as an intermediate in the synthesis of various drugs, resins, and corrosion inhibitors. The increasing demand for piperazine derivatives, especially in the pharmaceutical industry for the treatment of parasitic infections and neurological disorders, is driving market expansion. According to an article published in MDPI, piperazine is the third most prevalent nitrogen heterocycle in drug discovery and serves as a crucial component in several blockbuster pharmaceuticals, including Imatinib (marketed as Gleevec) and Sildenafil (sold as Viagra). Despite its extensive application in medicinal chemistry, the structural diversity of piperazines remains limited, with approximately 80% of piperazine-containing drugs featuring substituents exclusively at the nitrogen positions.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 3.45 Billion
Market Size 2030USD 4.49 Billion
CAGR 2025-20304.44%
Fastest Growing SegmentSynthetic
Largest MarketAsia Pacific

One of the key drivers of the piperazine market is its role in the pharmaceutical industry. Piperazine derivatives such as citrate and adipate salts are commonly used as anthelmintic drugs to treat infections caused by parasitic worms. Additionally, piperazine serves as a critical intermediate in the synthesis of psychiatric and anti-inflammatory drugs. The rising prevalence of parasitic infections, coupled with an increasing demand for effective medications, has boosted the consumption of piperazine-based pharmaceuticals. Another significant factor fuelling market growth is its application in the chemical and polymer industries. Piperazine is used in the production of epoxy resins, which are essential in coatings, adhesives, and composite materials. Also, it acts as a curing agent in polyurethane and polyamide resins, enhancing their mechanical properties. The growing construction, automotive, and aerospace industries are contributing to the rising demand for piperazine-based resins and polymers.

Key Market Drivers

Rising Demand in Pharmaceuticals

The global piperazine market is witnessing significant growth, primarily driven by its expanding application in the pharmaceutical industry. Piperazine, a versatile chemical compound, is widely used in the synthesis of various pharmaceutical drugs, particularly as an intermediate in producing anthelmintic medications, psychotropic drugs, and anti-tuberculosis treatments. The increasing prevalence of parasitic infections and neurological disorders, coupled with rising healthcare expenditures worldwide, is boosting the demand for piperazine-based pharmaceuticals. In March 2024, The Lancet Neurology published a major study revealing that in 2021, over 3 billion people globally had been living with a neurological condition. The World Health Organization (WHO) contributed to the analysis of the Global Burden of Disease, Injuries, and Risk Factor Study (GBD) 2021 data. The study confirmed that neurological conditions had become the leading cause of ill health and disability worldwide. Additionally, the total burden of disability, illness, and premature mortality-measured in disability-adjusted life years (DALYs)-had increased by 18% since 1990.

Key Market Challenges

Supply Chain Disruptions and Regional Dependencies

The global piperazine market is highly dependent on a few key manufacturing regions, such as China and India, which supply a substantial portion of the world's demand. Disruptions caused by trade restrictions, COVID-19-related lockdowns, or logistical bottlenecks can lead to supply shortages and price spikes. Additionally, reliance on a concentrated production base increases market vulnerability, making diversification a necessity but a challenging endeavor for companies seeking alternative suppliers.

Key Market Trends

Rising Demand for Carbon Capture Technologies

The increasing focus on reducing greenhouse gas emissions has led to significant advancements in carbon capture and storage (CCS) technologies, where piperazine-based solvents are playing a crucial role. As industries face stricter environmental regulations, CCS has emerged as a key strategy to curb CO2 emissions from power plants, industrial facilities, and oil refineries. Piperazine, known for its high reactivity with carbon dioxide, is being increasingly adopted in amine-based CO2 absorption processes to improve efficiency and reduce operational costs. According to the IEA, in 2023, the announced carbon capture capacity for 2030 increased by 35%, while the announced storage capacity grew by 70%. This expansion raised the total projected CO2 capture capacity for 2030 to approximately 435 million tonnes (Mt) per year, with the announced storage capacity reaching around 615 Mt of CO2 annually.

Traditionally, monoethanolamine (MEA) and diethanolamine (DEA) have been the primary solvents used for CO2 capture. However, these solvents often suffer from limitations such as low absorption capacity, high energy consumption for regeneration, and degradation over time. In contrast, piperazine has demonstrated superior reaction kinetics, higher CO2 absorption capacity, and improved thermal stability, making it an attractive alternative. It is commonly used in combination with other amines, such as methyldiethanolamine (MDEA) and MEA, to enhance the overall effectiveness of CO2 capture processes.

Key Market Players

  • BASF SE
  • Dow Inc.
  • Evonik Industries AG
  • Solvay S.A.
  • Albemarle Corporation
  • Shell plc
  • Huntsman Corporation
  • Akzo Nobel N.V.
  • Diamines and Chemicals Limited (DACL)
  • Shaoxing Xingxin New Materials Co., Ltd

Report Scope

In this report, the Global Piperazine Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Piperazine Market, By Source:

  • Natural
  • Synthetic

Piperazine Market, By Application:

  • Pharmaceutical
  • Agrochemicals
  • Personal Care & Cosmetics
  • Others

Piperazine Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Piperazine Market.

Available Customizations:

Global Piperazine Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, and Trends

4. Impact of COVID-19 on Global Piperazine Market

5. Global Piperazine Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value & Volume
  • 5.2. Market Share & Forecast
    • 5.2.1. By Source (Natural, Synthetic)
    • 5.2.2. By End Use (Pharmaceutical, Agrochemicals, Personal Care & Cosmetics, Others)
    • 5.2.3. By Region
    • 5.2.4. By Company (2024)
  • 5.3. Market Map

6. North America Piperazine Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value & Volume
  • 6.2. Market Share & Forecast
    • 6.2.1. By Source
    • 6.2.2. By End Use
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Piperazine Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Source
        • 6.3.1.2.2. By End Use
    • 6.3.2. Mexico Piperazine Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Source
        • 6.3.2.2.2. By End Use
    • 6.3.3. Canada Piperazine Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Source
        • 6.3.3.2.2. By End Use

7. Europe Piperazine Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value & Volume
  • 7.2. Market Share & Forecast
    • 7.2.1. By Source
    • 7.2.2. By End Use
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Piperazine Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Source
        • 7.3.1.2.2. By End Use
    • 7.3.2. Germany Piperazine Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Source
        • 7.3.2.2.2. By End Use
    • 7.3.3. United Kingdom Piperazine Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Source
        • 7.3.3.2.2. By End Use
    • 7.3.4. Italy Piperazine Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Source
        • 7.3.4.2.2. By End Use
    • 7.3.5. Spain Piperazine Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Source
        • 7.3.5.2.2. By End Use

8. Asia Pacific Piperazine Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value & Volume
  • 8.2. Market Share & Forecast
    • 8.2.1. By Source
    • 8.2.2. By End Use
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Piperazine Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Source
        • 8.3.1.2.2. By End Use
    • 8.3.2. India Piperazine Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Source
        • 8.3.2.2.2. By End Use
    • 8.3.3. South Korea Piperazine Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Source
        • 8.3.3.2.2. By End Use
    • 8.3.4. Japan Piperazine Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Source
        • 8.3.4.2.2. By End Use
    • 8.3.5. Australia Piperazine Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Source
        • 8.3.5.2.2. By End Use

9. South America Piperazine Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value & Volume
  • 9.2. Market Share & Forecast
    • 9.2.1. By Source
    • 9.2.2. By End Use
    • 9.2.3. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Piperazine Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Source
        • 9.3.1.2.2. By End Use
    • 9.3.2. Argentina Piperazine Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Source
        • 9.3.2.2.2. By End Use
    • 9.3.3. Colombia Piperazine Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Source
        • 9.3.3.2.2. By End Use

10. Middle East and Africa Piperazine Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value & Volume
  • 10.2. Market Share & Forecast
    • 10.2.1. By Source
    • 10.2.2. By End Use
    • 10.2.3. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Piperazine Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Source
        • 10.3.1.2.2. By End Use
    • 10.3.2. Saudi Arabia Piperazine Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Source
        • 10.3.2.2.2. By End Use
    • 10.3.3. UAE Piperazine Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Source
        • 10.3.3.2.2. By End Use

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Source Launches (If Any)
  • 12.3. Recent Developments

13. Global Piperazine Market: SWOT Analysis

14. Porters Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Product

15. Competitive Landscape

  • 15.1. BASF SE
    • 15.1.1. Business Overview
    • 15.1.2. Company Snapshot
    • 15.1.3. Products & Services
    • 15.1.4. Financials (As Reported)
    • 15.1.5. Recent Developments
    • 15.1.6. Key Personnel Details
    • 15.1.7. SWOT Analysis
  • 15.2. Dow Inc.
  • 15.3. Evonik Industries AG
  • 15.4. Solvay S.A.
  • 15.5. Albemarle Corporation
  • 15.6. Shell plc
  • 15.7. Huntsman Corporation
  • 15.8. Akzo Nobel N.V.
  • 15.9. Diamines and Chemicals Limited (DACL)
  • 15.10. Shaoxing Xingxin New Materials Co., Ltd

16. Strategic Recommendations

17. About Us & Disclaimer